Source author record

Junhua Zheng

Junhua Zheng appears in the imported research catalog. Authorship, coauthor and topic links are available while profile ownership is still unclaimed.

ResearcherUnclaimed source record

Catalog footprint

What is connected

3works
5topics
4close collaborators

Actions

Connect this record

Log in to claim

Research graph

See the researcher in context

Open full explorer

Inspect adjacent papers, topics, institutions and collaborators without losing the researcher page.

Building this map preview

BZPEER is loading the nearby papers, people, topics and institutions for this page.

Published work

3 published item(s)

preprint2023arXiv

A correspondence and distance of t-structures

For two t-structures $D_{1}=(D_{1}^{\leqslant 0},D_{1}^{\geqslant 1})$ and $D_{2}=(D_{2}^{\leqslant 0},D_{2}^{\geqslant 1})$ with $D_{1}^{\leqslant 0} \subseteq D_{2}^{\leqslant 0}$ on a triangulated category $\mathcal{D}$, we give a correspondence between t-structure $D_{i}=(D_{i}^{\leqslant 0},D_{i}^{\geqslant 1})$ which satisfies $D_{1}^{\leqslant 0} \subseteq D_{i}^{\leqslant 0} \subseteq D_{2}^{\leqslant 0}$ and a pair of full subcategories of $D_{1}^{\geqslant 1}\bigcap D_{2}^{\leqslant 0}$. Then we give a way to determine the distance of two t-structure if we have known that their distance is finite.In addition, if we set a t-structure $D_{1}$ whose heart $H_{1} \neq 0$ and that $H_{1}$ has a non-trivial torsion pair, then for any integer $n$, we can construct a t-structure $D_{2}$ such that the distance between $D_{1}$ and $D_{2}$ is $n$.

preprint2023arXiv

Artificial intelligence for diagnosing and predicting survival of patients with renal cell carcinoma: Retrospective multi-center study

Background: Clear cell renal cell carcinoma (ccRCC) is the most common renal-related tumor with high heterogeneity. There is still an urgent need for novel diagnostic and prognostic biomarkers for ccRCC. Methods: We proposed a weakly-supervised deep learning strategy using conventional histology of 1752 whole slide images from multiple centers. Our study was demonstrated through internal cross-validation and external validations for the deep learning-based models. Results: Automatic diagnosis for ccRCC through intelligent subtyping of renal cell carcinoma was proved in this study. Our graderisk achieved aera the curve (AUC) of 0.840 (95% confidence interval: 0.805-0.871) in the TCGA cohort, 0.840 (0.805-0.871) in the General cohort, and 0.840 (0.805-0.871) in the CPTAC cohort for the recognition of high-grade tumor. The OSrisk for the prediction of 5-year survival status achieved AUC of 0.784 (0.746-0.819) in the TCGA cohort, which was further verified in the independent General cohort and the CPTAC cohort, with AUC of 0.774 (0.723-0.820) and 0.702 (0.632-0.765), respectively. Cox regression analysis indicated that graderisk, OSrisk, tumor grade, and tumor stage were found to be independent prognostic factors, which were further incorporated into the competing-risk nomogram (CRN). Kaplan-Meier survival analyses further illustrated that our CRN could significantly distinguish patients with high survival risk, with hazard ratio of 5.664 (3.893-8.239, p < 0.0001) in the TCGA cohort, 35.740 (5.889-216.900, p < 0.0001) in the General cohort and 6.107 (1.815 to 20.540, p < 0.0001) in the CPTAC cohort. Comparison analyses conformed that our CRN outperformed current prognosis indicators in the prediction of survival status, with higher concordance index for clinical prognosis.

preprint2020arXiv

Supporting Real-Time COVID-19 Medical Management Decisions: The Transition Matrix Model Approach

Since the onset of the COVID-19 outbreak in Wuhan, China, numerous forecasting models have been proposed to project the trajectory of coronavirus infection cases. We propose a new discrete-time Markov chain transition matrix model that directly incorporates stochastic behavior and for which parameter estimation is straightforward from available data. Using such data from China's Hubei province (for which Wuhan is the provincial capital city), the model is shown to be flexible, robust, and accurate. As a result, it has been adopted by the first Shanghai assistance medical team in Wuhan's Jinyintan Hospital, which was the first designated hospital to take COVID-19 patients in the world. The forecast has been used for preparing medical staff, intensive care unit (ICU) beds, ventilators, and other critical care medical resources and for supporting real-time medical management decisions. Empirical data from China's first two months (January/February) of fighting COVID-19 was collected and used to enhance the model by embedding NPI efficiency into the model. We applied the model to forecast Italy, South Korea, and Iran on March 9. Later we made forecasts for Spain, Germany, France, US on March 24. Again, the model has performed very well, proven to be flexible, robust, and accurate for most of these countries/regions outside China.